Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019;15:275–89. https://doi.org/10.1038/s41581-019-0119-6.

Article  PubMed  PubMed Central  Google Scholar 

Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124:1094–112. https://doi.org/10.1161/CIRCRESAHA.118.313276.

Article  CAS  PubMed  Google Scholar 

Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review. J Am Coll Cardiol. 2020;76:1690–702. https://doi.org/10.1016/j.jacc.2020.08.014.

Article  CAS  PubMed  Google Scholar 

Gatford KL, Andraweera PH, Roberts CT, Care AS. Animal models of preeclampsia: causes, consequences, and interventions. Hypertension. 2020;75:1363–81. https://doi.org/10.1161/HYPERTENSIONAHA.119.14598.

Article  CAS  PubMed  Google Scholar 

Dimitriadis E, Rolnik DL, Zhou W, Estrada-Gutierrez G, Koga K, Francisco RPV, et al. Pre-eclampsia. Nat Rev Dis Primers. 2023;9:8 https://doi.org/10.1038/s41572-023-00417-6.

Article  PubMed  Google Scholar 

Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672–83. https://doi.org/10.1056/NEJMoa031884.

Article  CAS  PubMed  Google Scholar 

Verlohren S, Brennecke SP, Galindo A, Karumanchi SA, Mirkovic LB, Schlembach D, et al. Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia. Pregnancy Hypertens. 2022;27:42–50. https://doi.org/10.1016/j.preghy.2021.12.003.

Article  PubMed  Google Scholar 

Lala V, Franzese S. Role of sFlt-1/PlGF ratio in diagnosing preeclampsia. Am Fam Physician. 2024;109:470–1.

PubMed  Google Scholar 

Stepan H, Galindo A, Hund M, Schlembach D, Sillman J, Surbek D, et al. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction. Ultrasound Obstet Gynecol. 2023;61:168–80. https://doi.org/10.1002/uog.26032.

Article  CAS  PubMed  Google Scholar 

Jeon HR, Jeong DH, Lee JY, Woo EY, Shin GT, Kim SY. sFlt-1/PlGF ratio as a predictive and prognostic marker for preeclampsia. J Obstet Gynaecol Res. 2021;47:2318–23. https://doi.org/10.1111/jog.14815.

Article  CAS  PubMed  Google Scholar 

Ding G, Liping L, Moli D, Wuliyeti A, Shaohe Z, Huijuan W, et al. A study of the association between the sFlt-1/PlGF ratio and preeclampsia in Xinjiang Uygur Autonomous Region of China. Artif Cell Nanomed Biotechnol. 2018;46:S281–S6. https://doi.org/10.1080/21691401.2018.1491480.

Article  CAS  Google Scholar 

Balta S, Mikhailidis DP, Demirkol S, Ozturk C, Celik T, Iyisoy A. Endocan: a novel inflammatory indicator in cardiovascular disease? Atherosclerosis. 2015;243:339–43. https://doi.org/10.1016/j.atherosclerosis.2015.09.030.

Article  CAS  PubMed  Google Scholar 

Bueno-Sanchez JC, Gomez-Gutierrez AM, Maldonado-Estrada JG, Quintana-Castillo JC. Expression of placental glycans and its role in regulating peripheral blood NK cells during preeclampsia: a perspective. Front Endocrinol. 2023;14:1087845. https://doi.org/10.3389/fendo.2023.1087845.

Article  Google Scholar 

Kwiatkowska E, Stefanska K, Zielinski M, Sakowska J, Jankowiak M, Trzonkowski P, et al. Podocytes-the most vulnerable renal cells in preeclampsia. Int J Mol Sci. 2020;21:5051. https://doi.org/10.3390/ijms21145051.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hentschke MR, Lucas LS, Mistry HD, Pinheiro da Costa BE, Poli-de-Figueiredo CE. Endocan-1 concentrations in maternal and fetal plasma and placentae in pre-eclampsia in the third trimester of pregnancy. Cytokine. 2015;74:152–6. https://doi.org/10.1016/j.cyto.2015.04.013.

Article  CAS  PubMed  Google Scholar 

Cakmak M, Yilmaz H, Baglar E, Darcin T, Inan O, Aktas A, et al. Serum levels of endocan correlate with the presence and severity of pre-eclampsia. Clin Exp Hypertens. 2016;38:137–42. https://doi.org/10.3109/10641963.2015.1060993.

Article  CAS  PubMed  Google Scholar 

Croke L. Gestational hypertension and preeclampsia: a practice bulletin from ACOG. Am Fam Physician. 2019;100:649–50.

Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72:24–43. https://doi.org/10.1161/HYPERTENSIONAHA.117.10803.

Article  CAS  PubMed  Google Scholar 

Lee PF, Hsu TY, Tsai CC, Cheng HH, Lai YJ, Huang KL, et al. A comprehensive study of pre-eclampsia in IVF and natural conceptions: clinical phenotypes, perinatal outcomes and neonatal echocardiography. Reprod Biomed Online. 2024;49:103945. https://doi.org/10.1016/j.rbmo.2024.103945.

Article  PubMed  Google Scholar 

Muller A, Horvat V, Vulin M, Mandic S, Seric V, Vidosavljevic D. The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PlGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience. Med Glas. 2019;16:53–9. https://doi.org/10.17392/994-19.

Article  Google Scholar 

Hentschke MR, da Cunha Filho EV, Vieira MC, Paula LG, Mistry HD, Costa B, et al. Negative correlation between placental growth factor and endocan-1 in women with preeclampsia. Rev Bras Ginecol Obstet. 2018;40:593–8. https://doi.org/10.1055/s-0038-1670713.

Article  PubMed  PubMed Central  Google Scholar 

Chew BS, Ghazali R, Othman H, Ismail NAM, Othman AS, Laim N, et al. Endocan expression in placenta of women with hypertension. J Obstet Gynaecol Res. 2019;45:345–51. https://doi.org/10.1111/jog.13836.

Article  CAS  PubMed  Google Scholar 

Bacmeister L, Gossling A, Buellesbach A, Birukov A, Myers JE, Thomas ST, et al. High-sensitivity cardiac troponin I enhances preeclampsia prediction beyond maternal factors and the sFlt-1/PlGF ratio. Circulation. 2024;149:95–106. https://doi.org/10.1161/CIRCULATIONAHA.123.066199.

Article  CAS  PubMed  Google Scholar 

Lecarpentier E, Tsatsaris V. Angiogenic balance (sFlt-1/PlGF) and preeclampsia. Ann Endocrinol. 2016;77:97–100. https://doi.org/10.1016/j.ando.2016.04.007.

Article  Google Scholar 

Hod T, Cerdeira AS, Karumanchi SA. Molecular mechanisms of preeclampsia. Cold Spring Harb Perspect Med. 2015;5:a023473 https://doi.org/10.1101/cshperspect.a023473.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tataru-Copos AF, Popescu MI, Murvai R, El Kharoubi A. Efficiency of sFlt-1/PlGF ratio in preeclampsia diagnosis. Medicina. 2022;58:1196. https://doi.org/10.3390/medicina58091196.

Article  PubMed  PubMed Central  Google Scholar 

Droge LA, Perschel FH, Stutz N, Gafron A, Frank L, Busjahn A, et al. Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-ratio in the clinical routine: a Real-World Study. Hypertension. 2021;77:461–71. https://doi.org/10.1161/HYPERTENSIONAHA.120.15146.

Article  PubMed  Google Scholar 

Gannoun MBA, Mehdi M, Zitouni H, Boussabah M, Zouari I, Jlali A, et al. Evaluation of the angiogenic factors sFlt-1, PlGF, and the sFlt-1/PlGF ratio in preeclampsia and associated features. Am J Reprod Immunol. 2023;90:e13715 https://doi.org/10.1111/aji.13715.

Article  CAS  PubMed  Google Scholar 

Villalain C, Herraiz I, Valle L, Mendoza M, Delgado JL, Vazquez-Fernandez M, et al. Maternal and perinatal outcomes associated with extremely high values for the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) ratio. J Am Heart Assoc. 2020;9:e015548 https://doi.org/10.1161/JAHA.119.015548.

Article  PubMed  PubMed Central  Google Scholar 

Velegrakis A, Kouvidi E, Fragkiadaki P, Sifakis S. Predictive value of the sFlt‑1/PlGF ratio in women with suspected preeclampsia: an update (review). Int J Mol Med. 2023;52:89. https://doi.org/10.3892/ijmm.2023.5292.

Article